Introduction: The efficacy of chemotherapy in bacteraemia caused by nontyphoidal Salmonella (NTS) is compromised by antibiotic resistance. Objective: This study was undertaken to describe the mechanism of resistance among clinical NTS isolates. Materials & Methodology: Thirty of NTS were isolated from blood (n = 19), stool (n = 10) and bronchioalveolar lavage (BAL; n = 1) respectively. These isolates were tested for susceptibility testing by disc diffusion method against ampicillin, gentamicin, tetracycline, co-trimoxazole, nalidixic acid, ciprofloxacin and ceftriaxone. Epsilometer tests (E-test) for nalidixic acid and ciprofloxacin were performed for nalidixic acid resistant isolates by disc diffusion method. DNA sequencing was carried out on six of the nalidixic acid resistant Salmonella Enteritidis isolates to identify mutations within quinolones resistance determining regions (QRDR) of gyrA, gyrB, parC and parE genes. Results: Resistance rates of NTS isolates from blood, stool, and BAL were respectively 37%, 20% and 0% for ampicillin, 79%, 40% and 0% for tetracycline, 32%, 40% and 0% for co-trimoxazole, 37%, 10% and 100% for nalidixic acid. Eight isolates were resistant to nalidixic acid and had exhibited reduced susceptibility towards ciprofloxacin by E-test. Mutation 
Introduction
Antibiotics are used for the therapy of invasive diseases or complicated bacteraemia caused by non-typhoidal Salmonella (NTS). The prevalence of multidrug resistant NTS in adult patients has gradually increased in the last decade, making the treatment of invasive salmonellosis a clinical dilemma [1] [2] [3] [4] [5] .
Fluoroquinolones is a broad-spectrum antimicrobial agent that inhibits DNA gyrase in susceptible organisms and promotes breakage of double-stranded DNA. It is highly effective in urinary tract infections, gonorrhoea, invasive gastrointestinal infections, intra-abdominal infections and lower respiratory tract infections in adults [6] . It is also widely used in agriculture and veterinary medicine [2] [7] [8] [9] .
In principle there are four types of mechanism of antimicrobial resistance including inhibition of cell wall synthesis, inhibition of protein synthesis, inhibition of nucleic acid synthesis, and alteration of cell membrane function by which bacteria evade the action of antimicrobial agents. They work independently or in combination ranging from reduced susceptibility, which is not always detected by current antimicrobial susceptibility tests, to clinically relevant resistance. Resistance to quinolones is mainly mediated by chromosomal mutations which results to the target alteration of DNA gyrase and topoisomerase IV.
In Gram negative bacteria, the GyrA subunit of DNA gyrase is the most frequent primary target while topoisomerase IV are secondary target for quinolones. However, the contrary is true for Gram-positive bacteria [10] [11] .
Point mutations most often occur within the highly conserved domain of the N-terminus of the gyrA gene, also known as "quinolone resistance-determining region" (QRDR) [11] [12] . Most isolates resistant to nalidixic acid (NAL) have a single point mutation in the QRDR of gyrA, whilst resistance to ciprofloxacin is accomplished in isolates having double mutations in gyrA gene [12] [13] . Nalidixic aciddisc is used as "surrogate marker" to screen for reduced fluoroquinolone (FQ) susceptibility in Salmonella, as it has been shown that high resistance NAL is associated with reduced FQ susceptibility [4] . Nevertheless, the NAL screening may miss isolates that exhibit reduced FQ susceptibility by being Systematic epidemiological studies are required to determine the effect of reduced fluoroquinolone susceptibility on human health and its implications for treatment options. In vitro resistance to nalidixic acid isolates has been associated with reduced efficacy of fluoroquinolones in vivo [23] .
This study aims to identify the mechanism of chromosomal mutations involved in QRDR that leads to decreased CIP susceptibility among NTS isolates in Malaysia. Nevertheless, this information will serve as reference and surveillance tool for antibiotic resistance pattern that can be used at regional and international level. This could improve options for empirical antibiotic therapy and consequently, patient outcomes.
Materials and Methods
Salmonella strains: A total number of 30 NTS isolates belongs to 28 patients is defined as a MIC of ≥ 32 µg/ml while reduced susceptibility to CIP is defined as a MIC of ≥ 0.125 µg/ml as previously described [13] . All NAL-resistant isolates determined by E-test were examined for the mutation by PCR and sequence analysis.
Detection of target gene mutations: Polymerase chain reaction was used to amplify and screen the QRDR of gyrA, gyrB, parC and parE genes as previously described [25] using established primers [26] . Bands of the correct size were excised and purified using Wizard SV Gel and PCR Clean-Up System kit (Promega, Madison, USA) and were sent to Institute of Medical Molecular Bio-technology (IMMB), Faculty of Medicine, Universiti Teknologi MARA (Selangor, Malaysia) for sequencing. The sequences that were obtained were assembled using BioLign version 2.0.9 (http: //en.bio-soft.net/dna/BioLign.html) and the genes were compared to the respective genes in the Genbank using BLAST tool (http: //www.ncbi.nlm.nih.gov).
Results
The 30 NTS isolates were obtained from three types of specimen including blood (n = 19), stool (n = 10) and BAL (n = 1 Enteritidis were resistant to NAL and were isolated from the blood.
Sequence analysis revealed that six out of seven S. Enteritidis isolates had amino acid substitutions as a result of point mutations within QRDR of the gyrA gene. In three isolates, the aspartic acid at codon 47 was replaced with histidine (Asp 47 → His), while two other isolates had their aspartic acid at codon 51 and 73 substituted with asparagine (Asp 51 → Asn) and glycine (Asp 73 → Gly) residue respectively. In the remaining one isolate, glycine at codon 48 was resulted into aspartic acid substitution (Gly 48 → Asp).
In addition to it, amino acid substitutions were also observed due to a single base pair (T) insertion in parE gene from three isolates of S. Enteritidis. In all three isolates, glutamine at codon 81 was resulted into leucine substitution (Gln 81 → Leu) with glutamate at codon 82 was replaced by serine (Glu 82 → Ser).
Hence, all the six isolates of S. Enteritidis had point mutations at gyrA gene, and three isolates had mutation in both gyrA and parE gene. However, none of the S. Enteritidis isolates had mutation detected at gyrB and parC gene. A NAL MIC elevations (16 µg/mL) with increased resistance to CIP (0.5 µg/mL; 0.75 µg/mL) were detected in the other remaining isolates of S. Enteritidis and S. Corvallis.
The results are shown in Table 1 .
Discussion
In recent years, the proportion of NTS strains with reduced FQ susceptibility has increased in many countries including the United States, United Kingdom and [19], and reveal the increasing resistance of NAL with decreased susceptibility to CIP amongst NTS isolates in Malaysia. The NTS isolates were resistant to common antimicrobials (ampicillin and trimethoprim-sulfamethoxazole) and this concurs with previous related reports that described high resistance rate of NTS isolates to ampicillin, chloramphenicol and trimetophrim-sulfamethoxazole [23] , [29] .
Point mutations were identified on the DNA-binding surface of the enzyme near the putative active site tyrosine 122 in N terminal region of the GyrA [12] . Mutations within QRDR of parC and parE genes were rarely detected and reported among Salmonella isolates [25] [31] [32] . The finding of double mutations in parE gene in this study are remarkable, and may be associated with higher level of FQ resistance [30] [31] . In addition to it, parE gene mutations were identified in three S. Enteritidis isolates that were having gyrA gene muta-tions too. The isolates used in this study were resistant to nalidixic acid but susceptible to ciprofloxacin. These findings are in parallel to previous reports which suggested that multiple mutations are required for higher level of FQ resistance, while single mutation is important for resistance to quinolones [23] [31] [32] .
There is a possibility that an isolate of S. Enteritidis and S. Corvallis are harbouring the PMQR determinants, qnr and aac-6'-Ib-cr genes, as these isolates were susceptible to NAL with MIC: 16 µg/mL, and increased resistance to CIP (0.5 µg/mL; 0.75 µg/mL). However, another study needs to be carried out to identify and confirm the presence of PMQR determinant genes.
The data of this study impart the rate of nalidixic acid resistance and reduced ciprofloxacin susceptibility among non-typhoidal Salmonella clinical isolates in Malaysia. Novel amino acid exchanges found in this collection of isolates provides better understanding towards possible mechanisms that could be responsible for the nalidixic acid resistance and decreased ciprofloxacin susceptibility.
Despite small number of S. Enteritidis isolates in this study, the results obtained would be an essential reference for epidemiological and public health purposes especially in Malaysia, as well as in Southeast Asia region. Indirectly, this information will be constructive in modifying and deescalating the initial antimicrobial treatment.
In conclusion, the rate of nalidixic acid resistance and reduced susceptibility to ciprofloxacin is considered high in Malaysia. The resistance of S. Enteritidis isolates were essentially caused by point mutations in gyrA and parE genes. Furthermore S. Enteritidis is the most frequently isolated serotype causing bacteraemia, as all resistant isolates were isolated from the blood culture. Therefore, regional surveillance of antimicrobial resistance among non-typhoidal Salmonella isolates collected from food, animals and humans need to be enhanced to improve the management of invasive bacteraemia, particularly caused by S. Enteritidis, and to mitigate the increasing resistance rate of flouroquinolones.
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